A Qualitative Analysis of Factors Influencing HPV Vaccine Uptake in Soweto, South Africa among Adolescents and Their Caregivers

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Katz, Ingrid T ^a,b,c   Nkala, Busisiwe ^d   Dietrich, Janan ^d   Wallace, Melissa ^e   Bekker, Linda Gail ^e   Pollenz, Kathryn ^b   Bogart, Laura M ^b,f   Wright, Alexi A ^b,g   Tsai, Alexander C ^b,c   Bangsberg, David R ^b,c   Gray, Glenda E ^d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

^f BOSTON CHILDREN S HOSPITAL   (United States)

^g DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; ATTITUDE TO HEALTH; CAREGIVER; CHILD; CLINICAL RESEARCH; CULTURAL ANTHROPOLOGY; DECISION MAKING; DRUG RESEARCH; EPIDEMIC; FEMALE; HEALTH CARE PERSONNEL; HOUSEHOLD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INCOME; MALE; PAPILLOMAVIRUS INFECTION; PATIENT GUIDANCE; PERSONAL AUTONOMY; POVERTY; QUALITATIVE ANALYSIS; SCHOOL CHILD; SEMI STRUCTURED INTERVIEW; SEXUAL VIOLENCE; SEXUALLY TRANSMITTED DISEASE; SOCIAL ASPECT; SOCIAL SUPPORT; SOUTH AFRICA; VACCINATION; WART VIRUS;

ADOLESCENT; CAREGIVERS; CHILD; DECISION MAKING; FAMILY CHARACTERISTICS; FEMALE; HARM REDUCTION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; MALE; PAPILLOMAVIRUS VACCINES; QUALITATIVE RESEARCH; SEX OFFENSES; SEXUALLY TRANSMITTED DISEASES; SOUTH AFRICA; YOUNG ADULT;

EID: 84883323959     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072094     Document Type: Article

References (64)

1. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV, (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55: 244-265.
2. Denny LA, Franceschi S, de Sanjose S, Heard I, Moscicki AB, et al. (2012) Human papillomavirus, human immunodeficiency virus and immunosuppression. Vaccine 30Suppl 5: F168-174.
3. Firnhaber C, Van Le H, Pettifor A, Schulze D, Michelow P, et al. (2010) Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa. Cancer Causes Control 21: 433-443.
4. Omar T, Schwartz S, Hanrahan C, Modisenyane T, Tshabangu N, et al. (2011) Progression and regression of premalignant cervical lesions in HIV-infected women from Soweto: a prospective cohort. AIDS 25: 87-94.
5. UNAIDS (2011) South Africa.
6. Denny L, Kuhn L, De Souza M, Pollack AE, Dupree W, et al. (2005) Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. JAMA 294: 2173-2181.
7. Jones HE, Allan BR, van de Wijgert JH, Altini L, Taylor SM, et al. (2007) Agreement between self- and clinician-collected specimen results for detection and typing of high-risk human papillomavirus in specimens from women in Gugulethu, South Africa. J Clin Microbiol 45: 1679-1683.
8. Smith JS, Melendy A, Rana RK, Pimenta JM (2008) Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health 43: S5-25, S25 e21-41.
9. De Vuyst H, Ndirangu G, Moodley M, Tenet V, Estambale B, et al. (2012) Prevalence of human papillomavirus in women with invasive cervical carcinoma by HIV status in Kenya and South Africa. Int J Cancer 131: 949-955.
10. Denny L, (2006) Cervical cancer: the South African perspective. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 95Suppl 1: S211-214.
11. Denny L, (2008) Prevention of cervical cancer. Reprod Health Matters 16: 18-31.
12. Harries J, Moodley J, Barone MA, Mall S, Sinanovic E, (2009) Preparing for HPV vaccination in South Africa: key challenges and opinions. Vaccine 27: 38-44.
13. Katz IT, Wright AA, (2006) Preventing cervical cancer in the developing world. N Engl J Med 354: 1110.
14. Population Reference Bureau, PATH (2004) Preventing cervical cancer worldwide.
15. Fife KH, Wheeler CM, Koutsky LA, Barr E, Brown DR, et al. (2004) Dose-ranging studies of the safety and immunogenicity of human papillomavirus Type 11 and Type 16 virus-like particle candidate vaccines in young healthy women. Vaccine 22: 2943-2952.
16. Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, et al. (2004) Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 364: 1757-1765.
17. Paavonen J, Naud P, Salmeron J, Wheeler CM, Chow SN, et al. (2009) Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 374: 301-314.
18. Romanowski B, de Borba PC, Naud PS, Roteli-Martins CM, De Carvalho NS, et al. (2009) Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years. Lancet 374: 1975-1985.
19. Botha MH, Dochez C, (2012) Introducing human papillomavirus vaccines into the health system in South Africa. Vaccine 30Suppl 3: C28-34.
20. Motsoaledi A (2013) Address by the Minister of Health during the delivery of the Health Department Budget Vote; Cape Town.
21. Laz TH, Rahman M, Berenson AB, (2013) Human papillomavirus vaccine uptake among 18- to 26-year-old women in the United States: National Health Interview Survey, 2010. Cancer 119: 1386-1392.
22. Wong CA, Berkowitz Z, Dorell CG, Anhang Price R, Lee J, et al. (2011) Human papillomavirus vaccine uptake among 9- to 17-year-old girls: National Health Interview Survey, 2008. Cancer 117: 5612-5620.
23. Gerend MA, Shepherd MA, Shepherd JE, (2013) The multidimensional nature of perceived barriers: global versus practical barriers to HPV vaccination. Health Psychol 32: 361-369.
24. Gerend MA, Shepherd MA, Lustria ML, (2013) Increasing Human Papillomavirus Vaccine Acceptability by Tailoring Messages to Young Adult Women's Perceived Barriers. Sex Transm Dis 40: 401-405.
25. Wright TC, Bosch FX, Franco EL, Cuzick J, Schiller JT, et al. (2006) Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts. Vaccine 24Suppl 3: S3/251-261.
26. Bartolini RM, Drake JK, Creed-Kanashiro HM, Diaz-Otoya MM, Mosqueira-Lovon NR, et al. (2010) Formative research to shape HPV vaccine introduction strategies in Peru. Salud Publica Mex 52: 226-233.
27. PATH, National AIDS Research Institute (NARI) (2008) Assessing introduction of HPV vaccine in India: phase I formative study.
28. Katahoire AR, Jitta J, Arube-Wani J, Kivumbi G, Murokora D,et al. (2008) Formative research report: an assessment of the readiness for introduction of a cervical cancer vaccine in Uganda. Child Health and Development Center of Makerere University. Kampala.
29. Cover JK, Nghi NQ, LaMontagne DS, Huyen DT, Hien NT, et al. (2012) Acceptance patterns and decision-making for human papillomavirus vaccination among parents in Vietnam: an in-depth qualitative study post-vaccination. BMC Public Health 12: 629.
30. Nghi NQ, Lamontagne DS, Bingham A, Rafiq M, Mai le TP, et al. (2010) Human papillomavirus vaccine introduction in Vietnam: formative research findings. Sex Health 7: 262-270.
31. Bingham A, Drake JK, LaMontagne DS, (2009) Sociocultural issues in the introduction of human papillomavirus vaccine in low-resource settings. Arch Pediatr Adolesc Med 163: 455-461.
32. Nelson JA, Francis SA, Liverpool J, Soogun S, Mofammere N, (2010) Healers in a non-traditional role; a focus group study of Sangoma's knowledge of and attitudes to cervical cancer prevention and screening in Johannesburg, South Africa. Sex Reprod Healthc 1: 195-196.
33. Francis SA, Battle-Fisher M, Liverpool J, Hipple L, Mosavel M, et al. (2011) A qualitative analysis of South African women's knowledge, attitudes, and beliefs about HPV and cervical cancer prevention, vaccine awareness and acceptance, and maternal-child communication about sexual health. Vaccine 29: 8760-8765.
34. Mosavel M, Simon C, van Stade D, Buchbinder M, (2005) Community-based participatory research (CBPR) in South Africa: engaging multiple constituents to shape the research question. Soc Sci Med 61: 2577-2587.
35. Rehle TM, Hallett TB, Shisana O, Pillay-van Wyk V, Zuma K, et al. (2010) A decline in new HIV infections in South Africa: estimating HIV incidence from three national HIV surveys in 2002, 2005 and 2008. PLoS One 5: e11094.
36. Bekker LG (2009) Community attitudes towards adolescent involvement in HIV vaccine trials: a multi-centre South African study. Study Funder: European and Developing Countries Clinical Trials Partnership.
37. Creswell JW (1998) Qualitative Inquiry and Research Design: Choosing Among Five Traditions. Thousand Oaks, CA: Sage Publications.
38. Katz IT, Ware NC, Gray G, Haberer JE, Mellins CA, et al. (2010) Scaling up human papillomavirus vaccination: a conceptual framework of vaccine adherence. Sex Health 7: 279-286.
39. Crabtree BF, Miller WL (1999) Doing Qualitative Research. Thousand Oaks, CA: Sage Publications.
40. Corbin J, Strauss A (2008) Basics of Qualitative Resarch: Techniques and Procedures for Developing Grounded Theory. Los Angeles, CA: Sage Publications.
41. Willms DG, Best JA, Taylor DW, Gilbert JR, Wilson D, et al. (1990) A systematic approach for using qualitative methods in primary prevention research. Med Anthropol Q 4: 391-409.
42. Landis JR, Koch GG, (1977) The measurement of observer agreement for categorical data. Biometrics 33: 159-174.
43. Francis SA, Katz ML (2012) The HPV Vaccine: A Comparison of Focus Groups Conducted in South Africa and Ohio Appalachia. Matern Child Health J.
44. Francis SA, Nelson J, Liverpool J, Soogun S, Mofammere N, et al. (2010) Examining attitudes and knowledge about HPV and cervical cancer risk among female clinic attendees in Johannesburg, South Africa. Vaccine 28: 8026-8032.
45. Brabin L, Roberts SA, Farzaneh F, Kitchener HC, (2006) Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes. Vaccine 24: 3087-3094.
46. Fazekas KI, Brewer NT, Smith JS, (2008) HPV vaccine acceptability in a rural Southern area. J Womens Health 17: 539-548.
47. Shisana O, Rice K, Zungu N, Zuma K, (2010) Gender and poverty in South Africa in the era of HIV/AIDS: a quantitative study. J Womens Health 19: 39-46.
48. Hilton S, Patterson C, Smith E, Bedford H, Hunt K (2013) Teenagers' understandings of and attitudes towards vaccines and vaccine-preventable diseases: A qualitative study. Vaccine.
49. Alexander AB, Stupiansky NW, Ott MA, Herbenick D, Reece M, et al. (2012) Parent-son decision-making about human papillomavirus vaccination: a qualitative analysis. BMC Pediatr 12: 192.
50. Forster AS, Marlow LA, Wardle J, Stephenson J, Waller J, (2012) Interest in having HPV vaccination among adolescent boys in England. Vaccine 30: 4505-4510.
51. Reiter PL, McRee AL, Gottlieb SL, Brewer NT, (2010) HPV vaccine for adolescent males: acceptability to parents post-vaccine licensure. Vaccine 28: 6292-6297.
52. Hung KJ, Scott J, Ricciotti HA, Johnson TR, Tsai AC, (2012) Community-level and individual-level influences of intimate partner violence on birth spacing in sub-Saharan Africa. Obstet Gynecol 119: 975-982.
53. Tsai AC, Subramanian SV, (2012) Proximate context of gender-unequal norms and women's HIV risk in sub-Saharan Africa. AIDS 26: 381-386.
54. Adar J, Stevens M (2000) Womens Health. In: Ntuli A, Crisp N, Clarke E, editors. South African Health Review. Durban: Health Systems Trust. 411-427.
55. Crime Information Analysis Center (2001) The reported serious crime situation in South Africa for the period January- September 2001. In: South African Police Service Crime Analysis Center, editor. Pretoria.
56. Human Rights Watch (1995) Violence against women in South Africa: State response to domestic violence and rape.
57. Jewkes R, Abrahams N, (2002) The epidemiology of rape and sexual coercion in South Africa: an overview. Soc Sci Med 55: 1231-1244.
58. Smith K, Bryant-Davis T, Tillman S, Marks A, (2010) Stifled voices: barriers to help-seeking behavior for South African childhood sexual assault survivors. J Child Sex Abus 19: 255-274.
59. Statistics South Africa (2011) The data and metadata set from the Victims of Crime Survey, January 2010.
60. Department of Health (2011) National Antenatal Sentinel HIV and Syphilis Prevalence Survey in South Africa.
61. Conroy K, Rosenthal SL, Zimet GD, Jin Y, Bernstein DI, et al. (2009) Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. J Womens Health 18: 1679-1686.
62. Tsai AC, (2013) Intimate partner violence and population mental health: why poverty and gender inequities matter. PLoS Med 10: e1001440.
63. World Health Organization, London School of Hygiene and Tropical Medicine (2010) Preventing intimate partner violence and sexual violence against women: taking action and generating evidence.
64. Otwombe KN, Sikkema KJ, Dietrich J, de Bruyn G, van der Watt M, et al. (2011) Willingness to participate in biomedical HIV prevention studies after the HVTN 503/Phambili trial: a survey conducted among adolescents in Soweto, South Africa. J Acquir Immune Defic Syndr 58: 211-218.